v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
OPERATING ACTIVITIES      
Net income $ 15 $ 683 $ 600
Adjustments to determine net cash provided by operating activities:      
Depreciation and amortization 616 575 554
Loss (gain) on unrealized derivatives and other realized derivatives in investing activities, net 87 (44) 40
Gain on sale of business (7) 0 0
(Gain) loss on sale or disposal of assets, net (5) 4 6
Non-cash restructuring and impairment charges 92 34 28
Loss on extinguishment of debt, net 3 7 5
Deferred income taxes (193) (27) 20
Equity in net loss (income) of non-consolidated affiliates 2 (3) (4)
Loss (gain) on foreign exchange remeasurement of debt 17 (2) 2
Amortization of debt issuance costs and carrying value adjustments 15 13 12
Non-cash charges related to Sierre flooding 0 42 0
Non-cash charges related to Oswego fires 36 0 0
Other, net 3 3 3
Changes in assets and liabilities including assets and liabilities held for sale:      
Accounts receivable (542) (330) (25)
Inventories (1,300) (579) 185
Accounts payable 1,150 705 (119)
Other assets (287) (88) 42
Other liabilities 105 (42) (34)
Net cash (used in) provided by operating activities (193) 951 1,315
INVESTING ACTIVITIES      
Capital expenditures (2,343) (1,689) (1,358)
Acquisition of business and other investments 0 (2) 0
Proceeds from sales of assets, third party 14 0 0
Proceeds from the sale of a business 6 0 2
Proceeds (outflows) from investment in and advances to non-consolidated affiliates, net 7 (22) (36)
Outflows from settlement of derivative instruments, net (11) (14) (10)
Proceeds from insurance claims 145 25 0
Other 18 12 14
Net cash used in investing activities (2,164) (1,690) (1,388)
FINANCING ACTIVITIES      
Proceeds from issuance of long-term and short-term borrowings 1,779 2,268 749
Principal payments of long-term and short-term borrowings (836) (1,401) (736)
Revolving credit facilities and other, net 737 (361) (8)
Debt issuance costs (29) (34) (3)
Proceeds from equity contribution from our common shareholder 950 0 0
Return of capital to our common shareholder (35) 0 (100)
Net cash provided by (used in) financing activities 2,566 472 (98)
Net increase (decrease) in cash and cash equivalents and restricted cash 209 (267) (171)
Effect of exchange rate changes on cash 11 (14) (18)
Cash, cash equivalents and restricted cash — beginning of period 1,041 1,322 1,511
Cash, cash equivalents and restricted cash — end of period 1,261 1,041 1,322
Cash and cash equivalents 1,254 1,036 1,309
Restricted cash (included in other long–term assets) 7 5 13
Cash, cash equivalents and restricted cash — end of period 1,261 1,041 1,322
Supplemental Disclosures:      
Interest paid 242 247 279
Income taxes paid 180 250 173
Accrued capital expenditures as of March 31 $ 439 $ 250 $ 211

Source